Rebecca Lehto, PhD, RN, OCN, discusses patient use of complementary modalities during treatment for advanced lung cancer.
Rebecca Lehto, PhD, RN, OCN, assistant professor, College of Nursing, Michigan State University, discusses patient use of complementary modalities during treatment for advanced lung cancer.
Adagrasib Significantly Improves Responses, Survival in Advanced NSCLC Harboring KRAS G12C Mutation
June 3rd 2024Adagrasib, compared with standard-of-care chemotherapy, significantly improved tumor responses and progression-free survival in patients with KRASG12C-mutated locally advanced or metastatic NSCLC.